87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in
Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo
Researchers design novel immunotherapy for brain cancer

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm
Overcoming glioblastoma resistance to chemotherapy

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &
Colorectal cancer risk factors important to consider for rescreening interval

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C
Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si
New toolkit to support the collection of cancer-patient-reported outcome measures

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac
Opioids interfere with cancer immunotherapy, but another type of drug could help

Opioids interfere with cancer immunotherapy, but another type of drug could help

byUniversity of PittsburghCredit: Etatics Inc. from PexelsOpioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of

Opioids interfere with cancer immunotherapy, but another type of drug could help

byUniversity of PittsburghCredit: Etatics Inc. from PexelsOpioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of
Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d

Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d
Menopausal status influences long-term benefit from anti-hormonal treatment, study shows

Menopausal status influences long-term benefit from anti-hormonal treatment, study shows

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainToday, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low

Menopausal status influences long-term benefit from anti-hormonal treatment, study shows

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainToday, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low